When was Moderna founded?

Moderna was founded in 2010 and raised its 1st funding round 2 years after it was founded.

Where is Moderna located?

Moderna is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts.

How many employees does Moderna have?

As of Jun 30, 2026, the latest employee count at Moderna is 6249.

Is Moderna a funded company?

Moderna is a funded company, having raised a total of $2.78B across 22 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Nov 27, 2012.

When was the latest funding round of Moderna?

Moderna's latest funding was a $***** Grant (prize money) round on Jan 17, 2025, with participation from 1 investor.

What is the annual revenue of Moderna?

Annual revenue of Moderna is more than $1B as on Dec 31, 2025

Where does Moderna rank among its competitors?

Moderna ranks 7th amongst 2721 active competitors, of which 916 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Moderna?

Moderna's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Immuneel secured the most recent funding round in June, 2026.

Moderna - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of mRNA-based therapeutics for a wide range of diseases. The company produces human proteins, antibodies, or vaccines inside patient cells, which are in turn active intracellularly or secreted. The company is also developing vaccines in different disease areas such as infectious diseases, cancer, rare diseases, and COVID-19.

Website: www.modernatx.com/en-US
Social
Email ID: *****@modernatx.com
Phone Number: +1 **********
Registered Address: Cambridge, Massachusetts

Key Metrics

Founded Year

2010

Location

Cambridge, United States

Stage

Public

Total Funding

$2.78B in 22 rounds

Latest Funding Round

Grant (prize money), Jan 17, 2025, $*****

Investors

Merck & 33 more

Ranked

7^th among 2721 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

6,249 as on Jun 30, 2026

Investment & Acquisitions

OriCiro Genomics & 1 more

Similar Companies

Strand Therapeutics & 415 more

Exit Details

Public

View Moderna's full profile

Moderna is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Moderna Therapeutics Inc. CIN: 270226313 , United States, Active	Dec 31, 1999	-	4822 (As on Dec 31, 2024)	-
Modernatx, Inc. CIN: 204977193 , United States, Active	Dec 07, 2022	-	-	-
MODERNA, INC. CIN: 1682852 , United States, Active		$1B+ (As on Dec 31, 2025)	-	-

Moderna got listed on Dec 07, 2018.

Click here to take a look at Moderna's IPO in detail

Moderna has raised a total funding of $2.78B over 22 rounds. Its first funding round was on Nov 27, 2012. Its latest funding round was a Grant (prize money) round on Jan 17, 2025 for $*****. 1 investor participated in its latest round. Moderna has 34 institutional investors.

Here is the list of recent funding rounds of Moderna:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 17, 2025	6059330	Grant (prize money)	8452609	7771420	3061616	5185938
Jul 02, 2024	2324255	Grant (prize money)	2795011	6039613	8468313	8569312
Oct 08, 2020	4150064	Grant (prize money)	2766126	1072157	9405458	DARPA

Access funding benchmarks and valuations. Sign up today!

View details of Moderna's funding rounds and investors

The founders of Moderna are Timothy A Springer, Robert S Langer, Derrick Rossi and Kenneth R Chien.

Here are the details of Moderna's key team members:

Timothy A Springer: Co-Founder of Moderna. They are also an angel investor in 2 startups.
Contact Info: 1 email address
Robert S Langer: Co-Founder of Moderna.
Derrick Rossi: Co-Founder of Moderna.
Contact Info: 1 email address
Kenneth R Chien: Co-Founder of Moderna.

View details of Moderna's Founder profiles and Board Members

Moderna's employee count trend

Moderna has 6,249 employees as of Jun 26. Here is Moderna's employee count trend over the years:

Uncover Moderna's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Moderna include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Moderna, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
4th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, SV Health Investors & 17 others	72/100
5th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
6th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
7th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	ADS Ventures, Alcor Fund & 32 others	71/100
8th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
9th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, Eight Roads Ventures & 23 others	71/100
10th	Zymeworks 2003, Vancouver (Canada), Public	Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer	$146M	CTI Life Sciences Fund, Advanced Biotechnologies Venture Fund ... & 17 others	71/100